Ebola virus disease and the eye

  title={Ebola virus disease and the eye},
  author={Jessica G. Shantha and Steven Yeh and Quan Dong Nguyen},
  journal={Current Opinion in Ophthalmology},
Purpose of review The world has witnessed the largest Ebola virus disease (EVD) epidemic in West Africa with an unprecedented number of infected individuals and survivors. Many systemic and ocular complications have been reported in survivors. Herein, we review the ophthalmic complications associated with Ebolavirus. Recent findings EVD causes ocular disease during acute infection and during convalescence. Acute patients manifest with conjunctivitis, subconjunctival hemorrhages, and acute… Expand
Ebola virus infection
A severe, often fatal, zoonotic infection caused by a virus of the Filoviridae family (genus Ebolavirus); the lack of any specific antiviral treatment or approved vaccine makes treatment difficult. Expand
Post-exposure treatments for Ebola and Marburg virus infections
The current status of post-exposure medical countermeasures in development, including antibodies, small interfering RNA and small molecules are summarized, to outline how the current knowledge could be applied to the identification of novel interventions and ways to use interventions more effectively. Expand
Global Variations and Changes in Patterns of Infectious Uveitis
Progress in the understanding of intraocular inflammation led to the discovery that uveitis can be of infectious and noninfectious origin and that many pathogens can cause infectious Uveitis. Expand
Post Fever Uveoretinal Manifestations in an Immunocompetent Individual
Background: Post fever uveoretinal sequelae (PFURS) are the various uveoretinal manifestations seen after a systemic febrile illness in an immunocompetent individual caused by bacteria, viruses, andExpand
Host Transcriptional Response to Ebola Virus Infection
Ebola virus disease (EVD) is a serious illness that causes severe disease in humans and non-human primates (NHPs) and has mortality rates up to 90%. EVD is caused by the Ebolavirus and currentlyExpand
Filoviruses Can Efficiently Infect Human Neuron-Like Cells Without Genetic Adaptation
This study is the first to demonstrate that filoviruses are capable of infecting human neuron-like cells in a species-specific manner, and demonstrates that both Zaire ebolavirus and Marburg virus are capableof infecting cells derived from human brains without needing to change, and without killing the cells. Expand
Ebola Virus: Overview, Genome Analysis and Its Antagonists
After sequencing the Ebola virus genome, it has attracted the researchers, especially from Bioinformatics, Genomics, Transcriptomics, Proteomics and Metabolomics to analyze it and infer fruitful knowledge which can be used for efficient and robust drugs for EVD treatment approaches. Expand
Negative regulators that mediate ocular immune privilege
A greater understanding of immune privilege is provided in that it includes both molecular and cellular negative regulators of inflammation, which would mean that potentially new approaches to the treatment of autoimmune disease can be developed through the use of molecules and cells as negative regulator of inflammation. Expand
A multifaceted approach to improving management of sight-threatening non-infectious uveitis : patient perspectives and disease phenotyping for individualised patient therapy
The impacts of climate change will be felt for decades to come, according to scientists and decision-makers, and the impacts will vary widely from one generation to the next. Expand
Viruses go modular
This review summarizes key findings in this rapidly expanding field, in which new virus-host interactions continue to be identified, and expects that additional insights into these interactions will help support strategies to develop a new class of small-molecule inhibitors of viral PPxY-host WW-domain interactions that could be used as antiviral therapeutics. Expand


Sequelae of Ebola virus disease: the emergency within the emergency.
This Review assesses what is known regarding the sequelae of EVD, including possible delayed virus clearance, and discusses some of the key challenges regarding the provision of care to survivors and implementation of necessary future research. Expand
Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis.
This review aims to provide an overview of EVD for clinicians, with the emphasis on pathogenesis, clinical manifestations, and treatment options. Expand
Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study.
The findings underscore the need for early clinical follow-up of survivors of EVD and urgent provision of ocular care as part of health systems strengthening in EVD-affected west African countries. Expand
Persistence of Ebola Virus in Ocular Fluid during Convalescence.
A patient who recovered from EVD and was subsequently found to have severe unilateral uveitis during convalescence is described. Expand
Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease
A case of probable Zaire Ebola virus–related ophthalmologic complications in a physician from the United States who contracted Ebola virus disease in Liberia highlights immune phenomena that could complicate management of Ebola virus Disease–related uveitis during convalescence. Expand
Caring for the survivors of Uganda's Ebola epidemic one year on
After a year of Ebola hemorrhagic fever epidemic in Uganda 60 of 257 survivors are still suffering from complications of the disease, and most of the survivors have become poorer because they can no longer work as much as before they became ill. Expand
Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study.
Defining of health consequences related to Ebola virus disease could improve patient care for survivors and contribute to understanding of disease pathogenesis. Expand
Ebola haemorrhagic fever
Ebola virus infections are characterised by immune suppression and a systemic inflammatory response that causes impairment of the vascular, coagulation, and immune systems, leading to multiorgan failure and shock, and thus, in some ways, resembling septic shock. Expand
Clinical Management of Ebola Virus Disease in the United States and Europe.
Among the patients with EVD who were cared for in the United States or Europe, close monitoring and aggressive supportive care that included intravenous fluid hydration, correction of electrolyte abnormalities, nutritional support, and critical care management for respiratory and renal failure were needed; 81.5% of these patients who received this care survived. Expand
Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo.
Three of 20 survivors of the 1995 Ebola outbreak in the Democratic Republic of the Congo enrolled in a follow-up study and 1 other survivor developed ocular manifestations after being asymptomatic for 1 month, and ocular examination revealed uveitis in all 4 patients. Expand